Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2023 Dec 21;11(12):e8369.
doi: 10.1002/ccr3.8369. eCollection 2023 Dec.

A rare case of tumefactive demyelination of brain: A case report and literature review

Affiliations
Case Reports

A rare case of tumefactive demyelination of brain: A case report and literature review

Pugazhendi Inban et al. Clin Case Rep. .

Abstract

This case report highlights the diagnostic challenges encountered in a 30-year-old female presenting with fever followed by Wernicke's aphasia without right-sided weakness, ultimately diagnosed as tumefactive demyelination (TD). TD is a rare neurological condition often misidentified as brain tumors or inflammatory disorders. The case emphasizes the importance of precise differentiation through advanced magnetic resonance imaging, showing restricted diffusion at lesion edges and the absence of gadolinium enhancement. Accurate diagnosis is crucial for tailored treatment and prognostic assessment. This case contributes to our understanding of TD and underscores the need for continued research and collaboration in the field of rare neurological disorders.

Keywords: Wernicke's aphasia; cerebral spinal fluid (CSF); magnetic resonance imaging (MRI); magnetic resonance spectroscopy (MRS); multiple sclerosis; tumefactive demyelination (TD).

PubMed Disclaimer

Figures

FIGURE 1
FIGURE 1
Multi‐contrast Magnetic Resonance Imaging (MRI) Showing Mild Diffusion Restriction at the Edges of Brain Lesions Across Fluid Attenuated Inversion Recovery (FLAIR) and T2‐weighted (blue arrows).
FIGURE 2
FIGURE 2
MRS reveals normal metabolite levels in affected brain regions, providing clarity on NAA, creatine, choline, and lactate concentrations.

References

    1. Frohman EM, Racke MK, Raine CS. Multiple sclerosis – the plaque and its pathogenesis. N Engl J Med. 2006;354(9):942‐955. doi:10.1056/nejmra052130 - DOI - PubMed
    1. Noseworthy JH, Lucchinetti C, Rodriguez M, Weinshenker BG. Multiple sclerosis. N Engl J Med. 2000;343(13):938‐952. doi:10.1056/nejm200009283431307 - DOI - PubMed
    1. Caroli E, Salvati M, Ferrante L. Tumor‐like multiple sclerosis: report of four cases and literature review. Tumori. 2006;92(6):559‐562. doi:10.1177/030089160609200619 - DOI - PubMed
    1. Patriarca L, Torlone S, Ferrari F, et al. Is size an essential criterion to define tumefactive plaque? Mr features and clinical correlation in multiple sclerosis. Neuroradiol J. 2016;29(5):384‐389. doi:10.1177/1971400916665385 - DOI - PMC - PubMed
    1. Given CA, Stevens BS, Lee C. The MRI appearance of tumefactive demyelinating lesions. Am J Roentgenol. 2004;182(1):195‐199. doi:10.2214/ajr.182.1.1820195 - DOI - PubMed

Publication types

LinkOut - more resources